Developmental expression and activities of specific Fos and Jun proteins are functionally related to osteoblast maturation: Role of Fra-2 and Jun D during differentiation

Endocrinology

Volumn 137, Issue 10, 1996, Pages 4398-4408

  Mccabe, L R ^a   Banerjee, C ^a   Kundu, R ^a   Harrison, R J ^a   Dobner, P R ^a   Stein, J L ^a   Lian, J B ^a   Stein, G S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; OSTEOCALCIN; PROTEIN C FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BONE GROWTH; CELL DIFFERENTIATION; CELL MATURATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOBLOTTING; NONHUMAN; ONCOGENE; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION;

EID: 0029783822     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.10.8828501     Document Type: Article

References (56)

1. Kouzarides T, Ziff E 1988 The role of the leucine zipper in the Fos-Jun interaction. Nature 336:646-651
2. Angel P, Karin M 1991 The role of jun, fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072:129-157
3. Curran T, Franza BR 1988 Fos and Jun: the AP-1 connection. Cell 55:395-397
4. Hadman M, Loo M, Bos TJ 1993 In vivo viral and cellular jun complexes exhibit differential interactions with a number of in vitro generated AP-1- and CREB-like target sequences. Oncogene 8:1895-1903
5. Ryseck R, Bravo R 1991 c-JUN, JUN B and JUN D differ in their binding affinities to AP-1 and CRE consensus sequence: effect of FOS proteins. Oncogene 6:533-542
6. Sonnenberg JL, Rauscher FJ, Morgan JI, Curran T 1989 Regulation of proendephalin by Fos and Jun. Science 246:1622-1625
7. Gruda MC, Kovary K, Metz R, Bravo R 1994 Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9:2537-2547
8. Smeal T, Binetruy B, Mercola D, Grover-Bardwick A, Heidecker G, Rapp UR, Karin M 1992 Oncoprotein-mediated signalling cascade stimulates c-jun activity by phosphorylation of serine 63 and 73. Mol Cell Biol 12:3507-3513
9. Yamamoto KR, Pearce D, Thomas J, Miner JN 1992 Combinatorial regulation at a mammalian composite response element. In: McKnight SL, Yamamoto KR (eds) Transcriptional Regulation. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 1169-1192
10. Candeliere GA, Prud'homme J, St-Arnaud R 1991 Differential stimulation of fos and jun family members by calcitrol in osteoblastic cells. Mol Endocrinol 5:1780-1788
11. Clohisy JC, Scott DK, Brakenhoff KD, Quin CO, Partridge NC 1992 Parathyroid hormone induces c-fos and c-jun messenger RNA in rat osteoblastic cells. Mol Endocrinol 6:1834-1842
12. Lee K, Deeds JD, Chiba S, Un-No M, Bond AT, Segre GV 1994 Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids. Endocrinology 134:441-450
13. Merriman HL, LaTour D, Linkhart TA, Mohan S, Baylink DJ, Strong DD 1990 Insulin-like growth factor-I and insulin like growth factor-II induce c-fos in mouse osteoblastic cells. Calcif Tissue Int 46:258-262
14. Breen EC, Ignotz R, McCabe LR, Stein JL, Stein GS, Lian JB 1994 TGF-β alters growth and differentiation related gene expression in proliferating osteoblasts in vitro preventing development of the mature bone phenotype. J Cell Physiol 160:323-335
15. Machwate M, Jullienne A, Moukhtar M, Lomri A, Marie PJ 1995 c-fos protooncogene is involved in the mitogenic effect of transforming growth factor-β in osteoblastic cells. Mol Endocrinol 9:187-198
16. Dony C, Gruss P 1987 Proto-oncogene c-fos expression in growth regions of fetal bone and mesodermal web tissue. Nature 328:711-714
17. Ohta S, Yamamuro T, Lee K, Okumura, T, Kasai R, Hiraki Y 1991 Fracture healing induces expression of the proto-oncogene c-fos in vivo. Possible involvement of the Fos protein in osteoblastic differentiation. FEBS Lett 284:42-45
18. Wang Z, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF 1992 Bone and haematopoietic defects in mice lacking c-fos. Nature 360:741-745
19. Grigoriadis AE, Wang Z, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF 1994 c-fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443-450
20. Johnson RS, Spiegelman BM, Papaioannou V 1992 Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71:577-586
21. Ruther U, Garber C, Komitowski D, Muller R, Wagner EF 1987 Deregulation of c-fos expression interferes with normal bone development in transgenic mice. Nature 325:412-416
22. Grigoriadis AE, Wang Z, Wagner EF 1993 c-fos oncogene expression in cartilage and bone tissues of transgenic and chimeric mice. In: Noda M (ed) Cellular and Molecular Biology of the Bone. Academic Press, New York, pp 497-537
23. Owen TA, Bortell R, Yocum SA, Smock SL, Zhang M, Abate C, Shalhoub V, Aronin N, Wright KL, van Wijnen AJ, Stein JL, Curran T, Lian JB, Stein GS 1990 Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by fos-jun in the osteocalcin gene: model for phenotypic suppression of transcription. Proc Natl Acad Sci USA 87:9990-9994
24. Banerjee C, Stein JL, van Wijnen AJ, Kovary K, Bravo R, Frenkel B, Lian JB, Stein GS 1996 TGF-β1 response in the rat osteocalcin gene is mediated by an AP-1 binding site. Endocrinology 137:1991-2000
25. Merriman HL, van Wijnen AJ, Hiebert S, Bidwell JP, Fey E, Lian J, Stein J, Stein G 1995 The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBC2/runt domain transcription factor family: interactions with the osteocalcin promoter. Biochemistry 34:13125-13132
26. Banerjee C, Hiebert S, Stein J, Lian J, Stein GS 1996 An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci USA 93:4968-4973
27. McCabe LR, Stein JL, Lian JB, Bravo R, Stein GS 1995 Selective expression of fos and jun related genes during osteoblast proliferation and differentiation. Exp Cell Res 217:255-262
28. Lian JB, Stein GS 1992 Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med 3:269-305
29. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS 1990 Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420-430
30. Stein GS, Lian JB 1993 Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424-442
31. Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB 1990 Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 143:213-221
32. Bellows CG, Aubin JE, Heersche JN, Antosz ME 1986 Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 38:143-154
33. Bellows CG, Aubin JE, Heerche JNM 1987 Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 121:1985-1992
34. Shalhoub V, Conlon D, Tassinari M, Quinn C, Partridge N, Stein GS, Lian JB 1992 Glucocorticoids promote development of osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. J Cell Biochem 50:425-440
35. Sudo H, Kodama H, Amagai Y, Yamamoto S, Kasai S 1983 In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96:191-198
36. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ 1992 Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 7:683-689
37. Gundberg CM, Hauschka PV, Lian JB, Gallop PM 1984 Osteocalcin isolation, characterization, and detection. Methods Enzymol 173:534-545
38. Clark G 1981 Miscellaneous stains. In: Clark G (ed) Stain Procedures, ed 4. Williams and Wilkins, Baltimore, p 187
39. Bortell R, Owen TA, Bidwell JP, Gavazzo P, Breen E, van Wijnen AJ, DeLuca HF, Stein JL, Lian JB, Stein GS 1992 Vitamin D-responsive protein-DNA interactions at multiple promoter regulatory elements that contribute to the level of rat osteocalcin gene expression. Proc Natl Acad Sci USA 89:6119-6123
40. Towbin H, Staehelin T, Gordon J 1979 Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulse sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354
41. Sambrook J, Fritsch EF, Maniatis T 1988 Molecular Cloning-A Laboratory Manual, ed 2. Cold Spring Harbor Laboratory, Cold Spring Harbor
42. Lopata MA, Cleveland DW, Sollner-Webb B 1984 High level transient expression of a chloramphenicol acetylase transferase gene by DEAE-dextran mediated DNA transfection coupled with a dimethylsulfoxide or glycerol shock treatment. Nucleic Acids Res 12:5707-5717
43. Harrison RJ, McNeil GP, Dobner PR 1995 Synergistic activation of neurotensin/neuromedin N gene expression by c-jun and glucocorticoids: novel effects of Fos-family proteins. Mol Endocrinol 9:981-993
44. Schepmoes G, Breen E, Owen TA, Aronow MA, Stein GS, Lian JB 1991 Influence of dexamethasone on the vitamin D-mediated regulation of osteocalcin gene expression. J Cell Biochem 47:184-196
45. Aslam F, Shalhoub V, van Wijnen AJ, Banerjee C, Bortell R, Shakoori A, Litwack G, Stein JL, Stein GS, Lian JB 1995 Contributions of distal and proximal promoter elements to glucocorticoid regulation of osteocalcin gene transcription. Mol Endocrinol 9:679-690
46. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds) 1989 Current Protocols in Molecular Biology. Wiley and Sons, New York
47. Suzuki T, Okuno H, Yoshida T, Endo T, Nishina H, Iba H 1991 Differences in transcriptional regulatory function between c-fos and fra-2. Nucleic Acids Res 19:5537-5542
48. Birnbaum MJ, Wright KL, van Wijnen AJ, Ramsey-Ewing AL, Bourke MT, Last TJ, Aziz F, Frenkel B, Rao BR, Aronin N, Stein GS, Stein J 1995 Functional role for SP-1 in the transcriptional amplification of a cell cycle regulated histone H4 gene. Biochemistry 34:7648-7658
49. Guo B, van Wijnen AJ, Stein JL, Stein GS, Lian JB 1995 Transcriptional regulator YY-1 inhibits vitamin D receptor (VDR)/RXR mediated enhancement of osteocalcin transcription in vivo. Mol Biol Cell 6:74a
50. Schule R, Umensono K, Mangelsdorf DJ, Bolado J, Pike JW, Evans RM 1990 Jun-Fos, receptors for vitamins A, D recognize a common response element in the human osteocalcin gene. Cell 61:497-504
51. Kovary K, Bravo R 1991 The Jun and Fos protein families are both required for cell cycle progression in fibroblasts. Mol Cell Biol 9:4466-4472
52. 1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins. Mol Cell Biol 12:5015-5023
53. Rezzonico R, Loubat A, Lallemand D, Pfarr CM, Far DF, Proudfoot A, Rossi B, Ponzio G 1995 Cyclic AMP stimulates a Jun D/Fra-2 AP-1 complex and inhibits the proliferation of interleukin-6-dempendent cell lines. Oncogene 11:1069-1078
54. Matsui M, Tokuhara M, Konuma Y, Nomura N, Ishizaki R 1989 Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation. Oncogene 5:249-255
55. Stephens JM, Butts MD, Pekala PH 1992 Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumor necrosis factor-alpha. J Mol Endocrinol 9:61-72
56. Szabo E, Preis LH, Brown PH, Birrer MJ 1991 The role of jun and fos gene family members in 12-O-tetradecanoylphorbol-13-acetate induced hemopoietic differentiation. Cell Growth Differ 2:475-482